Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05886881 · ClinicalTrials.gov registry record
Air Optix Extended Wear Contact Lenses
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 505
- Enrollment target
NCT05886881 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 505 participants.
The verdict
NCT05886881 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 505 participants
- Enrollment target
Study Summary
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix Aqua Sphere, Air Optix plus HydraGlyde Sphere, and Air Optix plus HydraGlyde Toric soft contact lenses in a real-world setting when worn as extended (overnight) wear.
Interventions
- DEVICE Lotrafilcon B spherical soft contact lenses
- DEVICE Lotrafilcon B spherical soft contact lenses with comfort additive
- DEVICE Lotrafilcon B toric soft contact lenses with comfort additive
- DEVICE Comfilcon A spherical soft contact lenses
- DEVICE Comfilcon A toric soft contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 505 participants |
| Start Date | 2023-08-03 |
| Est. Completion | 2025-04-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05886881
The ClinicalTrials.gov registry entry for NCT05886881 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 505 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Lotrafilcon B spherical soft contact lenses is the first listed.
NCT05886881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05886881 about?
NCT05886881 is a clinical study titled "Air Optix Extended Wear Contact Lenses". The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix Aqua Sphere, Air Optix plus HydraGlyde Sphere, and Air Optix plus HydraGlyde Toric soft contact lenses in a real-world setting when worn as extended (overnight) wear.
What is the current status of trial NCT05886881?
This trial is currently completed. The enrollment target is 505 participants. The study started on 2023-08-03. Estimated completion is 2025-04-15.
What interventions are being tested in trial NCT05886881?
The interventions under investigation include: Lotrafilcon B spherical soft contact lenses (DEVICE), Lotrafilcon B spherical soft contact lenses with comfort additive (DEVICE), Lotrafilcon B toric soft contact lenses with comfort additive (DEVICE), Comfilcon A spherical soft contact lenses (DEVICE), Comfilcon A toric soft contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05886881?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.